These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2743854)

  • 21. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control.
    White NH; Waltman SR; Krupin T; Santiago JV
    Diabetes; 1982 Jan; 31(1):80-5. PubMed ID: 6759217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-retina barrier permeability in diabetes during acute ACE-inhibition.
    Engler CB; Parving HH; Mathiesen ER; Larsen M; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1991 Oct; 69(5):581-5. PubMed ID: 1776410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study.
    Engler C; Krogsaa B; Lund-Andersen H
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):442-6. PubMed ID: 1937077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypotony and aqueous humor dynamics in myotonic dystrophy.
    Walker SD; Brubaker RF; Nagataki S
    Invest Ophthalmol Vis Sci; 1982 Jun; 22(6):744-51. PubMed ID: 7076420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy].
    Bordat B; Guirgis IR; Manderscheid JC
    J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
    Parving HH; Larsen M; Hommel E; Lund-Andersen H
    Diabetologia; 1989 Jul; 32(7):440-4. PubMed ID: 2680698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and function of the corneal endothelium in diabetes mellitus type I and type II.
    Larsson LI; Bourne WM; Pach JM; Brubaker RF
    Arch Ophthalmol; 1996 Jan; 114(1):9-14. PubMed ID: 8540858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
    Retina; 1995; 15(2):134-40. PubMed ID: 7624601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitreous fluorophotometry in insulin-dependent diabetes mellitus. Correlation with microalbuminuria and diastolic blood pressure.
    Jackson WE; Chase HP; Garg SK; Bartlett DA; Hoops S; Harris S; Marshall G; Ishimoto BM
    Arch Ophthalmol; 1990 Dec; 108(12):1733-5. PubMed ID: 2256845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posterior vitreous fluorophotometry. II. Comparison of diabetic patients and controls with the use of a new analysis procedure.
    Roy MS; Bungay PM; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1328-33. PubMed ID: 2675803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of basal tear turnover in insulin-dependent diabetes mellitus patients by fluorophotometry.
    Stolwijk TR; van Best JA; Lemkes HH; de Keizer RJ; Oosterhuis JA
    Int Ophthalmol; 1991 Nov; 15(6):377-82. PubMed ID: 1778668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular fluorophotometry in the normal- and diabetic monkey.
    Jones CW; Cunha-Vaz JG; Zeimer RC; Rusin MM; Langenberg PW; Vygantas CM; Tso MO; Jonasson O
    Exp Eye Res; 1986 May; 42(5):467-77. PubMed ID: 3720865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The blood-retinal barrier permeability to fluorescein in normal subjects and in juvenile diabetics without retinopathy.
    Krogsaa B; Lund-Andersen H; Mehlsen J; Sestoft L
    Acta Ophthalmol (Copenh); 1986 Apr; 64(2):173-9. PubMed ID: 3727957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorophotometry in juvenile-onset diabetes: long-term follow-up.
    Krupin T; Waltman SR
    Jpn J Ophthalmol; 1985; 29(2):139-45. PubMed ID: 4046222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
    Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-retinal barriers in juvenile diabetics in relation to early clinical manifestations, HLA-DR types, and metabolic control.
    Kernell A; Ludvigsson J
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):250-3. PubMed ID: 3856546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An 18-month vitreous fluorophotometric follow-up study in juvenile diabetics.
    Benitez del Castillo JM; Castillo A; Garcia Sanchez J; Ruibal JL; Reverte F; Ibarra JM
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):651-6. PubMed ID: 8109211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of permeability in blood-retinal barrier.
    Kojima M; Yoshida A; Ishiko S; Tanaka K
    Hokkaido Igaku Zasshi; 1990 Jul; 65(4):419-27. PubMed ID: 2227794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitreous fluorophotometry in juvenile diabetics after oral fluorescein.
    Nuzzi G; Vanelli M; Venturini I; Bonacini M; Boselli E
    Arch Ophthalmol; 1986 Nov; 104(11):1630-1. PubMed ID: 3778277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intraocular barrier permeability in spontaneously diabetic Chinese hamster].
    Fukui Y; Yoshida A; Nomiyama T; Takahashi M; Kojima M
    Nippon Ganka Gakkai Zasshi; 1992 Mar; 96(3):328-34. PubMed ID: 1580215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.